Concerto: Study for Late-Stage Age-Related Macular Degeneration (AMD)

Listen to Page Audio

What is Late-Stage Age-Related Macular Degeneration (AMD)?

Late-stage age-related macular degeneration (AMD) is an advanced form of AMD, where damage to the central vision area of the retina, the macula, occurs. Late-stage AMD is the leading cause of irreversible vision loss for people over 60 years old.

 

Signs & Symptoms

  • Vision distortions (straight lines may appear wavy or bent)
  • Decreased central vision (blurry or blind spot in vision)
  • Need for brighter lights when reading
  • Reduced brightness of colors

 

Happy elderly couple looking at tablet device together Female wearing glasses

Late-Stage Age-Related Macular Degeneration Study Design

A clinical study to test the safety and effectiveness of an implantable miniature telescope (IMT) in patients with central vision impairment associated with late- stage age-related macular degeneration (AMD).

Purpose & Importance

The purpose of this device is to magnify what a patient is seeing and project this image onto the retina, enabling the patient to recognize and identify objects that could not otherwise be seen.

Things to Consider

  • You will have access to clinical study experts, including ophthalmologists, that can answer any questions you have throughout the entire journey.
  • Your ocular and systemic health will be closely monitored over the course of the study.
  • There will be separately scheduled visits with a low vision occupational therapist who will help you learn about your “new vision.”
  • Our team has a strong background in age-related macular degeneration (AMD) and medical device clinical trials.

Study for Late-Stage Age-Related Macular Degeneration (AMD)

We’re conducting a clinical study to evaluate an implantable miniature telescope (IMT) device for central vision loss associated with late-stage age-related macular degeneration (AMD).

Condition

Age-Related Macular Degeneration

Study Status

Icon for study status

Currently Enrolling

Study Length

Icon for 5 visits

5 visits over 12-15 months plus vision rehabilitation

Compensation

Eligible patients will be compensated for each study visit.

Current Locations

Icon for current locations

Lawrence, MA
Erie, PA
Sarasota, FL
Pasadena, CA
Manasquan, NJ
Whippany, NJ
Madison, WI
Eatontown, NJ

Upcoming Locations

Icon for upcoming locations

We are adding new locations for this study regularly. Please fill out the form below to learn more.

Contact us for more information about this study.

Key Requirements

Key Inclusion Criteria

  • Participants must be at least 65 years old on the pre-operative visit date
  • Participants must have decreased vision associated with late-stage AMD

Key Exclusion Criteria

  • Participants cannot have had previous cataract surgery in the study eye
Listen to Page Audio

DOWNLOAD BROCHURE TO FIND OUT MORE

Back to clinical trial